On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Sherry Shi

ResearcherPublications, citations & collaboration network

Sherry Shi is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Sherry Shi have?

ScholarIQindexed works

Sherry Shi has 72 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Sherry Shi have?

ScholarIQcitation count

Sherry Shi has 515 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Sherry Shi?

ScholarIQh-index

Sherry Shi has an h-index of 13 in OpenAlex.

What is the i10-index of Sherry Shi?

ScholarIQi10-index

Sherry Shi has an i10-index of 17 in OpenAlex.

What is the OpenAlex record for Sherry Shi?

ScholarIQopenalex

The OpenAlex for Sherry Shi is on the source record.

What are the most-cited papers on Sherry Shi?

ScholarIQmost cited works
Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States
Stephen J. Greene, Taylor Triana, Raluca Ionescu‐Ittu, Sherry Shi, Annie Guérin, Mary M. DeSouza, Paul Kessler, Aylin Tuğcu, Maria Borentain, G. Michael Felker
Journal of the American College of Cardiology. 202150 Citations
Overall survival in patients with glioblastoma before and after bevacizumab approval
Derek R. Johnson, Antonio Omuro, Arliene Ravelo, Nicolas Sommer, Annie Guérin, Raluca Ionescu‐Ittu, Sherry Shi, Alex Macalalad, Joon H. Uhm
Current Medical Research and Opinion. 201742 Citations
Treatment patterns, healthcare resource utilization, and costs in patients with acute myeloid leukemia in commercially insured and Medicare populations
Eytan M. Stein, Gaetano Bonifacio, Dominick Latrémouille-Viau, Annie Guérin, Sherry Shi, Patrick Gagnon‐Sanschagrin, Owanate Briggs, George J Joseph
Journal of Medical Economics. 201842 CitationsOPEN ACCESS
Economic burden of relapse/recurrence in patients with major depressive disorder
Geneviève Gauthier, Lisa Mucha, Sherry Shi, Annie Guérin
Journal of Drug Assessment. 201936 CitationsOPEN ACCESS
Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States
Michael L. Volk, Rebecca Burne, Annie Guérin, Sherry Shi, George J Joseph, Zeev Heimanson, Maliha Ahmad
Journal of Medical Economics. 202128 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial